We are live on ! Find out more
CLB icon

Core Laboratories

194 hedge funds and large institutions have $1.05B invested in Core Laboratories in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 59 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

920% more call options, than puts

Call options by funds: $3.06M | Put options by funds: $300K

26% more capital invested

Capital invested by funds: $830M → $1.05B (+$218M)

24% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 59

6.42% more ownership

Funds ownership: 103.75%110.17% (+6.4%)

3% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 29

2% less funds holding

Funds holding: 197194 (-3)

Holders
194
Holders Change
-3
Holders Change %
-1.52%
% of All Funds
2.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
28
Increased
73
Reduced
59
Closed
29
Calls
$3.06M
Puts
$300K
Net Calls
+$2.76M
Net Calls Change
-$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
SI
26
Scout Investments
Missouri
$5.21M -$436K -24,617 -9%
ACM
27
Advisors Capital Management
New Jersey
$4.82M +$58.7K +3,316 +1%
Principal Financial Group
28
Principal Financial Group
Iowa
$4.73M -$174K -9,847 -4%
Norges Bank
29
Norges Bank
Norway
$4.69M -$810K -45,793 -17%
Russell Investments Group
30
Russell Investments Group
United Kingdom
$4.58M +$2.78M +157,252 +230%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$4.32M -$553K -31,260 -13%
CWM
32
Congress Wealth Management
Massachusetts
$3.88M +$142K +8,036 +4%
Wells Fargo
33
Wells Fargo
California
$3.02M -$57K -3,221 -2%
Legal & General Group
34
Legal & General Group
United Kingdom
$2.97M +$2.58M +145,790 +23,900%
CIM
35
Confluence Investment Management
Missouri
$2.85M -$95.1K -5,376 -4%
N
36
Nuveen
North Carolina
$2.8M
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$2.79M -$129K -7,317 -5%
Bank of America
38
Bank of America
North Carolina
$2.73M +$114K +6,424 +5%
UBS AM
39
UBS AM
Illinois
$2.42M +$590K +33,339 +39%
Goldman Sachs
40
Goldman Sachs
New York
$2.3M +$468K +26,435 +30%
Public Sector Pension Investment Board (PSP Investments)
41
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.09M +$110K +6,212 +6%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.86M
Marshall Wace
43
Marshall Wace
United Kingdom
$1.64M -$740K -41,819 -34%
QEI
44
QSV Equity Investors
Illinois
$1.61M -$47.9K -2,708 -3%
PWM
45
Partnership Wealth Management
Maryland
$1.59M -$843K -47,614 -38%
Citadel Advisors
46
Citadel Advisors
Florida
$1.57M -$5.55M -313,866 -80%
MC
47
Moors & Cabot
Massachusetts
$1.53M +$1.77K +100 +0.1%
TC
48
TownSquare Capital
Utah
$1.43M +$173K +9,786 +16%
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$1.28M -$169K -9,543 -13%
MAA
50
Mraz Amerine & Associates
California
$1.26M -$22.2K -1,257 -2%

CLB Hedge Fund Activity: Q2 2024 in Review

194 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2024, worth a combined $1.05B — up 26% from $830M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CLB and 28 opened new positions — a net loss of 1 holder — while 59 trimmed existing stakes and 73 added.

The largest buyer was Disciplined Growth Investors, adding an estimated $64.5M. The largest seller was Ariel Investments, cutting an estimated $9.44M.

  • 194 institutional investors held Core Laboratories (CLB) as of Q2 2024, down from 197 in Q1 2024.
  • Funds reported $1.05B of Core Laboratories stock for Q2 2024, up 26% quarter-over-quarter.
  • 28 funds opened new Core Laboratories positions in Q2 2024 and 29 closed out, a net change of -1 holder.
  • The largest Core Laboratories buyer in Q2 2024 was Disciplined Growth Investors, an estimated $64.5M added.
  • The largest Core Laboratories seller in Q2 2024 was Ariel Investments, an estimated $9.44M sold.

Based on aggregated 13F filings for Q2 2024.